Physician profile
Bruce M Silverstein
NPI 1063472918
$2,947.15
in general payments reported to CMS, 2019-2025
19 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,115 · 2020: $309 · 2021: $71.68 · 2022: $460 · 2023: $353 · 2024: $393 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $755 · Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $755.00 |
| Food and Beverage | $236.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sekisui Diagnostics LLC | $1,100.00 | 2022-2025 | |
| Novo Nordisk INC | $373.82 | 2019 | |
| Genzyme Corporation | $350.00 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $317.59 | 2019-2024 | Farxiga |
| Glaxosmithkline, LLC. | $184.63 | 2019 | |
| Astellas Pharma US INC | $138.12 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $131.68 | 2019-2021 | |
| Lilly USA, LLC | $110.77 | 2019-2023 | Jardiance |
| Pfizer INC. | $45.11 | 2019 | |
| Amarin Pharma, INC. | $39.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.95 | 2019 | |
| Supernus Pharmaceuticals, INC. | $24.90 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.55 | 2019 | |
| Medtronic USA, INC. | $18.65 | 2020 | |
| Biodelivery Sciences International, INC. | $15.16 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.76 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $11.94 | 2019 | |
| Merck Sharp & Dohme LLC | $11.71 | 2019 | |
| Abbvie INC. | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Silverstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.